LI Korytova*, DA Sklyar, AV Pavlovsky, EV Vlasova, AA Polikarpov, OV Korytov and VE Moiseenko
Federal State Budgetary Institution "Russian Scientific Center of Radiology and Surgical Technologies Named After Academician A.M. Granov" of Ministry of Health of the Russian Federation, St. Petersburg, Russia
*Corresponding Author: LI Korytova, Federal State Budgetary Institution "Russian Scientific Center of Radiology and Surgical Technologies Named After Academician A.M. Granov" of Ministry of Health of the Russian Federation, St. Petersburg, Russia.
Received: September 28, 2021; Published: October 25, 2021
In the article “The role of radiotherapy in neoadjuvant treatment of patients with operable pancreatic head cancer” results of the combined neoadjuvant treatment of operable pancreatic cancer were presented. Patients, suffering from pancreatic cancer (n = 40) were randomized into two arms and compared arm one: intra-arterial chemotherapy + radiation therapy + operation (n = 20) vs arm two: intra-arterial chemotherapy + operation (n = 20).
Neoadjuvant radiation therapy was performed with 2 fractions per day 2 Gy each with 4-6 hours between them 5 days a week up until summary dose of 50 Gy. Neoadjuvant radiation therapy with a double fractioning per day had proven to be safe and effective. Arm 1 had statistically verified lower postoperative pancreatitis frequency and chances to develop fistulas, higher number of second degree pathomorphosis
outcomes, as well as life expectancy median.
Keywords: Radiation Therapy; Pancreatic Cancer; Double Day Fractioning
Citation: LI Korytova., et al. “The Role of Radiotherapy in Neoadjuvant Treatment of Patients with Operable Pancreatic Head Cancer”. Acta Scientific Gastrointestinal Disorders 4.11 (2021): 36-42.
Copyright: © 2021 LI Korytova., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.